Healthtech funding in H1 2010
European Healthtech startup funding raised during H1 2010.
In H1 2010, 23 European Healthtech companies closed 23 funding rounds and raised €206M in equity funding (excluding debt and grants), up 48.4% versus H1 2009. Germany led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 6 Nov 2026.
Equity funding
€206M
+48.4% vs H1 2009 · excl. debt & grants
Funding rounds
23
+109.1% vs H1 2009
Companies
23
Top country
Germany
Rank among sectors
#1
18.6% of sector funding
Top-10 round share
84.8%
of disclosed capital
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, H1 2010 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €27M | 5 |
| Mar | €46M | 4 |
| Apr | €74M | 7 |
| May | €52M | 4 |
| Jun | €7.7M | 3 |
Top countries
by € raisedHealthtech — top countries by capital, H1 2010 — interactive chart.
Data table
| Healthtech — top countries by capital, H1 2010 | |
|---|---|
| Germany | €55M |
| Switzerland | €51M |
| UK | €37M |
| France | €28M |
| Israel | €17M |
| Spain | €8.0M |
| Finland | €5.8M |
| Ireland | €4.6M |
Stage mix
by € raisedHealthtech — stage mix, H1 2010 — interactive chart.
Data table
| Healthtech — stage mix, H1 2010 | |
|---|---|
| Series B | €64M |
| Series C | €60M |
| Other | €53M |
| Series A | €21M |
| Early VC | €7.2M |
| Seed | €813k |
| Grant | €656k |
Top deals
largest disclosed rounds in H1 2010| Company | Stage | Date | Amount |
|---|---|---|---|
| Biocartis | Series B | Apr 2010 | €30M |
| CureVac | Series C | May 2010 | €26M |
| WILEX | Other | Mar 2010 | €24M |
| Oxford Nanopore Technologies | Series C | Apr 2010 | €21M |
| CeQur | Series A | Jan 2010 | €21M |
| Genticel | Series C | Apr 2010 | €13M |
| Valtech Cardio | Series B | Mar 2010 | €13M |
| Nanobiotix | Other | May 2010 | €9.9M |
| Funxional Therapeutics | Series B | May 2010 | €9.2M |
| TCD Pharma | Other | Mar 2010 | €8.0M |
| Carebase | Early VC | May 2010 | €6.7M |
| Pharnext | Other | Jun 2010 | €5.2M |
| Oncos Therapeutics | Other | Apr 2010 | €5.0M |
| Veryan Medical | Series B | Apr 2010 | €4.0M |
| ActiViews | Series B | Jan 2010 | €3.5M |
Top investors
most active in H1 2010, by deal count- High-Tech Gründerfonds (HTGF)2 deals
- Advent Venture Partners1 deals
- Aescap1 deals
- Amundi Private Equity Funds1 deals
- Aurinvest1 deals
- Bayern Kapital1 deals
- Clave Mayor1 deals
- Earlybird Venture Capital1 deals
- Edmond de Rothschild Venture Capital1 deals
- HealthCap1 deals